Teladoc Health Inc

TDOC

Equity

ISIN US87918A1051 / Valor 28438140

New York Stock Exchange, Inc (2024-09-18)

USD 9.09-0.22%

Teladoc Health Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

focus on providing virtual healthcare services through a network of U.S. board-certified healthcare professionals, including internists, family doctors, nurse practitioners, dermatologists, psychiatrists, and pediatricians. The company offers a wide range of medical specialties, allowing patients to receive diagnosis, treatment, and prescriptions for common non-emergency health issues via phone or video consultations. Additionally, Teladoc Health connects patients with global medical specialists for complex conditions, treatment plans, and surgeries. The company's services are accessible to individuals in the U.S. and Canada, with licensed physicians available in various provinces and states to provide personalized care from anywhere.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue

Teladoc Health Inc. reported a revenue of $642.4 million for the Second Quarter of 2024, which represents a 2% decrease compared to the $652.4 million reported in the Second Quarter of 2023. The decline was primarily driven by a 3% decrease in access fees revenue, partially offset by an 8% increase in other revenue.

Net Loss

For the Second Quarter of 2024, Teladoc Health Inc. recorded a net loss of $837.7 million, or $4.92 per share. This significant loss includes a non-cash goodwill impairment charge of $790.0 million, or $4.64 per share, which was related to changes in estimates of future cash flows for the company’s BetterHelp segment.

Adjusted EBITDA

Teladoc Health Inc. reported an adjusted EBITDA of $89.5 million for the Second Quarter of 2024, marking a 24% increase from the $72.2 million reported in the Second Quarter of 2023. The Integrated Care segment contributed significantly to this growth with a 69% increase in adjusted EBITDA to $64.0 million.

Segment Performance

In the Second Quarter of 2024, Teladoc Health Inc.'s Integrated Care segment saw a revenue increase of 5% to $377.4 million, while the BetterHelp segment experienced a 9% decline in revenue to $265.0 million. The contrasting performance between the segments highlights the varied market dynamics affecting the company.

Financial Outlook

Teladoc Health Inc. has withdrawn its financial outlook for the full year of 2024 for its consolidated operations and the BetterHelp segment. However, the company provided guidance for the Integrated Care segment, expecting low to mid-single-digit revenue growth and an adjusted EBITDA margin expansion of 150 to 200 basis points for the full year of 2024.

Summarized from source with an LLMView Source

Key figures

-56.2%1Y

-93.7%3Y

-86.5%5Y

Performance

51.5%1Y

69.5%3Y

66.4%5Y

Volatility